ā Back to Trial
Neoadjuvant ADT + Darolutamide With Pembrolizumab, Followed by Adjuvant Pembrolizumab in Molecularly Stratified High-Risk Prostate Cancer
Trial Locations
-
Icahn School of Medicine at Mount Sinai
New York, New York, United States
- Contact: Darren Deoraj, MHA Ā· [email protected] (opens in new tab)

